Mayo experts work with the companies to understand AI model requirements, check for fairness and bias in their AI models, help them understand the Food and Drug Administration clearance process and more.
Through the alliance, the two organizations are sharing their extensive clinical data with one another, which will help identify diseases and treatment plans earlier.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Decentralized and hybrid clinical trials have a faster enrollment rate and a higher retention rate than centralized models, research shows.
Novartis is partnering with algorithms startup Anumana to develop a new artificial intelligence-based solution for cardiovascular diseases. The goal is to find ways to detect heart conditions years before symptoms develop in order to enable earlier intervention.
Hospital-at-home advocates often highlight how the care modality improves the patient experience and allows hospitals to better manage capacity. There are other key benefits — such as protecting patients from hospital-acquired infections and improving caregiver's job satisfaction — that should be brought into the conversation as well, hospital executives say.
Early detection and treatment of heart failure can greatly improve an otherwise poor prognosis. Research from Mayo Clinic suggests artificial intelligence could be used to detect the condition even when no symptoms are present.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
PathAI is partnering with Cleveland Clinic to digitize pathology slides and develop and improve PathAI's machine-learning algorithms that can drive research as well as improve patient outcomes in a clinical setting. Pramana is launching its digital pathology as a service product and has struck a multi-year commercial agreement with Mayo Clinic to digitize 5 million pathology slides.
They led an investment in TripleBlind, a Kansas City-based startup looking to support collaboration between healthcare companies without the need to share raw data.
Eleven health systems have joined the coalition, which aims to extend and expand the existing federal hospital-at-home waivers and create an advanced acute care-at-home delivery model at the Center for Medicare & Medicaid Innovation.
Judges proclaimed winners across three tracks of the digital health startup pitch contest including: Home health, chronic disease management and value-based care, and technology to support payer and provider efficiency.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The algorithm maps interactions between different areas of the brain, which can help guide the placement of electrodes for stimulating devices to treat brain diseases, like epilepsy, and movement disorders.
They plan to commercialize the decision support software, which would surface relevant patient records and recommendations from Mayo Clinic specialists. To start, they will focus on cardiometabolic conditions.
Google is piloting its healthcare data engine, a tool intended to build longitudinal patient records and pull in data from multiple sources. Early work with Mayo Clinic served as a foundation for the technology.
A new analysis from the Lown Institute identified the most and least racially inclusive hospitals in America, but hospitals at the bottom of the list dispute the methodology. Still, the analysis indicates a troubling trend of racial segregation in healthcare.
The health systems are sinking a combined $100 million into Medically Home Group, which enables clinicians to provide hospital-level care in patients' homes. The funds are intended to scale the company's operations and expand access to its care delivery model.